Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Pieber

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|May 27, 2018
The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysisS Heller, K Bowering, P Raskin, et al.
European Journal of Endocrinology|July 25, 2009
Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndromeE Wehr, S Pilz, N Schweighofer, et al.
Diabetes Care|May 1, 1995
Evaluation of a structured outpatient group education program for intensive insulin therapyT R Pieber, G A Brunner, W J Schnedl, et al.
Diabetes, Obesity & Metabolism|November 24, 2015
Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trialH W Rodbard, B Cariou, T R Pieber, et al.
Diabetes, Obesity & Metabolism|April 10, 2015
Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trialT R Pieber, S Deller, S Korsatko, et al.
Diabetes, Obesity & Metabolism|May 29, 2016
Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4T Blevins, T R Pieber, G Colón Vega, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Erectile dysfunction in patients with type I diabetes mellitus]G A Brunner, T R Pieber, S Schattenberg, et al.
The Cochrane Database of Systematic Reviews|April 21, 2006
Short acting insulin analogues versus regular human insulin in patients with diabetes mellitusA Siebenhofer, J Plank, A Berghold, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 27, 2007
Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapyT R Pieber, H-C Treichel, B Hompesch, et al.
Diabetologia|July 20, 2004
Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-upJ Plank, G Köhler, I Rakovac, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Diabetic Medicine : a Journal of the British Diabetic Association|May 27, 2018
The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysisS Heller, K Bowering, P Raskin, et al.
European Journal of Endocrinology|July 25, 2009
Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndromeE Wehr, S Pilz, N Schweighofer, et al.
Diabetes Care|May 1, 1995
Evaluation of a structured outpatient group education program for intensive insulin therapyT R Pieber, G A Brunner, W J Schnedl, et al.
Diabetes, Obesity & Metabolism|November 24, 2015
Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trialH W Rodbard, B Cariou, T R Pieber, et al.
Diabetes, Obesity & Metabolism|April 10, 2015
Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trialT R Pieber, S Deller, S Korsatko, et al.
Diabetes, Obesity & Metabolism|May 29, 2016
Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4T Blevins, T R Pieber, G Colón Vega, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Erectile dysfunction in patients with type I diabetes mellitus]G A Brunner, T R Pieber, S Schattenberg, et al.
The Cochrane Database of Systematic Reviews|April 21, 2006
Short acting insulin analogues versus regular human insulin in patients with diabetes mellitusA Siebenhofer, J Plank, A Berghold, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 27, 2007
Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapyT R Pieber, H-C Treichel, B Hompesch, et al.
Diabetologia|July 20, 2004
Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-upJ Plank, G Köhler, I Rakovac, et al.
Pageof 9